Clinical Trials Directory

Trials / Unknown

UnknownNCT05462223

Alucent Vessel Restoration System for AVF

A Study of the Safety and Feasibility of the Vessel Restoration System for AVF to Promote the Physiologic and Functional Maturation of Upper-extremity Autologous End-to-Side Arteriovenous Fistulas (AVF) in Patients With Chronic Kidney Disease: ACTIVATE AVF

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Alucent Biomedical · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Feasibility of the Vessel Restoration System for AVF

Detailed description

A study of the safety and feasibility of the Vessel Restoration System for AVF to promote the physiologic and functional maturation of a Brachiocephalic End-to-Side Arteriovenous Fistulas (AVF) in Patients with Chronic Kidney Disease Stage V (Pre-dialysis): ACTIVATE AVF

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTAlucent Vessel Restoration System for AVFAlucent Vessel Restoration System for AVF (VRS-AVF) consists of the following components: 1. VRS 10-8-10 Dimer Coated Balloon Catheter for AVF 2. VRS Light Fiber 3. VRS Light Source

Timeline

Start date
2022-07-15
Primary completion
2024-05-15
Completion
2024-12-15
First posted
2022-07-18
Last updated
2024-03-13

Locations

12 sites across 2 countries: Australia, Poland

Source: ClinicalTrials.gov record NCT05462223. Inclusion in this directory is not an endorsement.

Alucent Vessel Restoration System for AVF (NCT05462223) · Clinical Trials Directory